Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.69 USD | -0.88% |
|
0.00% | -11.05% |
06-06 | I-Mab Appoints Phillip Dennis as Chief Medical Officer | CI |
06-05 | I-Mab Collaborates With Bristol-Myers to Evaluate Givastomig in Combination Study for Gastric, Esophageal Cancers | MT |
Sales 2024 * | 750K 59.31M | Sales 2025 * | 750K 59.31M | Capitalization | 138M 10.88B |
---|---|---|---|---|---|
Net income 2024 * | -143M -11.31B | Net income 2025 * | -146M -11.55B | EV / Sales 2024 * | 183 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 183 x |
P/E ratio 2024 * |
-1.18
x | P/E ratio 2025 * |
-1.56
x | Employees | 220 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 84.84% |
Latest transcript on I-Mab
1 day | -0.88% | ||
Current month | +1.81% | ||
1 month | -3.43% | ||
3 months | -9.63% | ||
6 months | +4.97% | ||
Current year | -11.05% |
![Extreme 1.66](/images/extremecours_fleche.png)
![Extreme 1.51](/images/extremecours_fleche.png)
![Extreme 1.48](/images/extremecours_fleche.png)
![Extreme 1.16](/images/extremecours_fleche.png)
![Extreme 1.16](/images/extremecours_fleche.png)
![Extreme 1.16](/images/extremecours_fleche.png)
![Extreme 1.16](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Rajkumar Kannan
CEO | Chief Executive Officer | 61 | 21/06/23 |
Jerry Wang
CTO | Chief Tech/Sci/R&D Officer | - | - |
Yi Fei Zhu
PRN | Corporate Officer/Principal | 55 | 09/08/20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chia Hung Yang
BRD | Director/Board Member | 61 | 31/12/19 |
Pamela Klein
CHM | Chairman | 63 | 31/12/19 |
Shuai Chen
BRD | Director/Board Member | 50 | 31/03/23 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.79% | 96 M€ | -.--% | - | |
0.57% | 4 M€ | -27.92% | ||
0.03% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.00% | 4 M€ | -4.41% | - |
Date | Price | Change | Volume |
---|---|---|---|
27/06/24 | 1.69 | -0.88% | 99,601 |
26/06/24 | 1.705 | -0.87% | 163,140 |
25/06/24 | 1.72 | 0.00% | 54,741 |
24/06/24 | 1.72 | +2.38% | 85,140 |
21/06/24 | 1.68 | -0.59% | 95,766 |
Delayed Quote Nasdaq, June 27, 2024 at 09:00 pm
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.05% | 138M | |
+55.95% | 811B | |
+43.62% | 640B | |
-6.98% | 353B | |
+19.08% | 333B | |
+9.05% | 302B | |
+16.30% | 246B | |
+2.41% | 225B | |
+12.47% | 218B | |
+8.91% | 168B |
- Stock Market
- Equities
- IMAB Stock